"
User:DavidC/31 August 2009
From 2009.igem.org
(Difference between revisions)
(New page: {{Template:Supbiotechcss6.css}} {{Template:SupbiotechparisEn}} <center> <div style="color: black; margin-bottom: 30px; width: 500px;"> {|align="center" ||{{#calendar: title=User:DavidC |...) |
|||
| Line 12: | Line 12: | ||
</div> | </div> | ||
</center> | </center> | ||
| + | |||
| + | |||
| + | === Week from the 31th of August to the 7th of September === | ||
| + | |||
| + | Ligation and restriction test for plasmid design (protocol, trial…). <br><br> | ||
| + | Maxiprep, 500mL of DHL on LB medium, with Nucleobond PC 200. Samples: <br> | ||
| + | B0030, B0014. <br> | ||
Revision as of 02:13, 21 October 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
Week from the 31th of August to the 7th of September
Ligation and restriction test for plasmid design (protocol, trial…).
Maxiprep, 500mL of DHL on LB medium, with Nucleobond PC 200. Samples:
B0030, B0014.
